Daewoong reporting business performance up to 3Q of 2005.

Published: 2006-02-17 06:56:00

Updated: 2006-02-17 06:56:00

Daewoong reported the business performances for the first 9 months of FY2005 (Apr. 1 to Dec. 31, 2005) at 247,300 million won of sales, 33,553 million won of operating incomes, 33,357 million won of ordinary incomes and 23,727 million won of net incomes (25,878 million won in the previous year pe...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK